We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+4.06%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$558M
AUM Growth
+$80.9M
(+17%)
Cap. Flow
+$74.9M
Cap. Flow
% of AUM
13.41%
Top 10 Holdings %
Top 10 Hldgs %
4.09%
Holding
1,998
New
778
Increased
301
Reduced
272
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$3.2M |
| 2 |
Boeing
BA
|
+$2.64M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.42M |
| 4 |
Amgen
AMGN
|
+$2.03M |
| 5 |
Elevance Health
ELV
|
+$1.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.64M |
| 2 |
Lockheed Martin
LMT
|
+$2.31M |
| 3 |
Cigna
CI
|
+$2.21M |
| 4 |
Wells Fargo
WFC
|
+$2.18M |
| 5 |
Paychex
PAYX
|
+$1.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.12% |
| 2 | Healthcare | 15.64% |
| 3 | Consumer Discretionary | 14.34% |
| 4 | Industrials | 14.21% |
| 5 | Financials | 12.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Masco
MAS
$16B
| $1.04M | 0.19% |
18,102
+12,709
| +236% | +$665K |
|
77
Zimmer Biomet
ZBH
$17.7B
| $1.03M | 0.19% |
7,094
+1,499
| +27% | +$204K |
|
78
Tandem Diabetes Care
TNDM
$1.17B
| $1.03M | 0.18% |
+42,039
| New | +$1.35M |
|
|
EXAS
79
DELISTED
Exact Sciences
EXAS
| $1.02M | 0.18% |
+10,907
| New | +$851K |
|
80
Vertiv
VRT
$112B
| $1.02M | 0.18% |
41,171
+1,839
| +5% | +$31.6K |
|
81
SS&C Technologies
SSNC
$17.8B
| $1.02M | 0.18% |
16,817
+9,771
| +139% | +$556K |
|
82
Commercial Metals
CMC
$7.63B
| $1.02M | 0.18% |
+19,298
| New | +$900K |
|
83
VF Corp
VFC
$6.68B
| $1.01M | 0.18% |
+52,846
| New | +$1.08M |
|
84
Apogee Enterprises
APOG
$850M
| $1.01M | 0.18% |
21,212
+15,685
| +284% | +$654K |
|
85
ConocoPhillips
COP
$147B
| $1M | 0.18% |
9,681
+960
| +11% | +$98.6K |
|
86
Applied Materials
AMAT
$426B
| $1M | 0.18% |
6,936
+4,439
| +178% | +$556K |
|
|
SKX
87
DELISTED
Skechers
SKX
| $1M | 0.18% |
19,035
+14,708
| +340% | +$753K |
|
88
Pultegroup
PHM
$24.5B
| $1,000K | 0.18% |
+12,867
| New | +$872K |
|
89
Fidelity National Information Services
FIS
$21.5B
| $991K | 0.18% |
+18,112
| New | +$997K |
|
90
Vertex Pharmaceuticals
VRTX
$121B
| $985K | 0.18% |
2,799
+1,170
| +72% | +$394K |
|
91
Halliburton
HAL
$27.9B
| $980K | 0.18% |
29,721
+21,627
| +267% | +$683K |
|
92
Camden Property Trust
CPT
$11.3B
| $976K | 0.17% |
8,965
+6,670
| +291% | +$719K |
|
93
Builders FirstSource
BLDR
$7.84B
| $968K | 0.17% |
+7,121
| New | +$792K |
|
94
Intuitive Surgical
ISRG
$121B
| $968K | 0.17% |
2,831
-1,821
| -39% | -$551K |
|
95
Ryanair
RYAAY
$29.5B
| $967K | 0.17% |
21,855
+15,597
| +249% | +$629K |
|
96
Roper Technologies
ROP
$36.3B
| $964K | 0.17% |
2,006
-2,354
| -54% | -$1.07M |
|
97
Thor Industries
THO
$3.99B
| $954K | 0.17% |
+9,220
| New | +$779K |
|
98
Kroger
KR
$34.8B
| $953K | 0.17% |
20,273
+14,252
| +237% | +$680K |
|
99
SLB Ltd
SLB
$77.8B
| $951K | 0.17% |
+19,354
| New | +$923K |
|
100
Stanley Black & Decker
SWK
$14.2B
| $949K | 0.17% |
+10,129
| New | +$838K |
|
Similar funds
HW
AAM
RWM
SAM
FWI
PP
VH
TSW
XTX Topco's Q2 2023 Portfolio in Review
As of Q2 2023, XTX Topco held 1,998 positions worth $558M, up 17% from $477M the previous quarter. Its ten largest holdings account for 4.1% of the portfolio.
XTX Topco deployed $74.9M of net new capital in Q2 2023, opening 778 new positions and adding to 301 existing holdings. Its largest new stake was Target: 21,561 shares worth $2.84M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Lockheed Martin, an estimated $2.31M trimmed.
- XTX Topco's largest Q2 2023 buy was Target: 21,561 shares worth $2.84M.
- XTX Topco added most to Alphabet (Google) Class A in Q2 2023, an estimated $2.42M increase.
- XTX Topco's biggest Q2 2023 reduction was Lockheed Martin, cutting an estimated $2.31M.
- XTX Topco fully exited Regeneron Pharmaceuticals in Q2 2023, selling an estimated $2.64M.
- XTX Topco's ten largest holdings make up 4.1% of its $558M portfolio in Q2 2023.
- XTX Topco opened 778 new positions and closed 643 in Q2 2023.
- XTX Topco's portfolio value rose 17% quarter-over-quarter to $558M.
Based on XTX Topco's 13F filing for Q2 2023, filed 14 Aug 2023.